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Asthma:
Diagnosis and Management
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Top 5 things to know about Asthma
1.
2.
3.
4.
5.

It is a chronic disease
Spirometry can be diagnostic, quick and easy
Level of severity is consistent over time
Assessing control guides treatment
Asthma Action Plans can improve outcomes
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Case
 45 year old woman calls in requesting cough syrup. She
had a recent treated pneumonia about 6 weeks ago and
has been unable to stop coughing. She has a history of
reactive airways and occasional albuterol use.

Make an appointment!
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Asthma is a chronic disease
 22 million Americans
 6 million children
 Significant societal burden
>
>
>
>
>

Lost work & school
Lessened quality of life
Avoidable ED visits
Hospitalizations
Deaths
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Pathophysiology
• Bronchospasm
• Airway hyper-responsiveness
• Airway edema (chronic
inflammation)
• Remodeling and scar
Cause:
• Innate immunity
• Genetics
• Environmental factors
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Symptoms







Wheezing
Recurrent cough
Recurrent wheeze
Recurrent difficulty in breathing
Recurrent chest tightness
Worsened by
•
•
•
•
•
•
•
•

Exercise
Viral infection
Inhalant allergens
Irritants (wood smoke)
Changes in weather
Strong emotion
Stress
Menstrual cycles

 Nocturnal symptoms/sleep disturbance
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Evaluation
 Detailed medical history
• Symptoms + pattern
• Aggravating factors
• Development of disease
> treatment history
> history of exacerbations

• Family History
• Social History
> Impact of asthma on patient and family
> Assessment of patient’s and family’s perception of disease
> Smoking history or exposure

 Physical examination
• Full HEENT and Pulmonary exam
• Elicit a forced expiration (have children blow a tissue)

 Spirometry
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Differential Diagnosis















Rhinitis or Sinusitis
Foreign Body/Mass
Aspiration
Laryngotracheomalacia
Vocal Cord Dysfunction (VCD)
Viral bronchiolitis or bronchitis
Cystic Fibrosis
Heart Disease
Habit cough (or other non-asthma cough)
GERD
COPD
CHF
Pulmonary Embolus
Medication Side Effect
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Spirometry (as easy as an EKG)
 Standard
• 3 efforts of 6 second forced exhalation
• with an inspiratory loop
• More reliable than peak flow but effort dependent

 With Reversibility
• Give 2-4 puffs of an albuterol inhaler (with a spacer) or an albuterol
nebulizer treatment
• Repeat in 15 minutes
• Significant response = 12 % and 200cc improvement in FEV1 and or
FVC

 Intervals
•
•
•
•

Initial assessment
Once controlled
During prolonged or progressive exacerbations
Every 1-2 years
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Spirometry Demonstration
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Spirometry Interpretation
 Step 1: assess ratio of FEV1/FVC
• < 90% predicted = airflow limitation
• ≥ 90% predicted with abnormal values, refer for further pulmonary
function testing

 Step 2: assess absolute level of FEV1 to quantify
severity
Degree of severity
Mild
Moderate
Moderately Severe
Severe
Very Severe

FEV1 % predicted
> 70
60-69
50-59
35-45
< 35

 Step 3: assess response to bronchodilator
• Significant response = 12 % and 200 cc increase in FEV1 and/or FVC
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Reversible Airflow Limitation
Volume

FEV1/FVC < 90% predicted

Postbronchodilator
FEV1

FEV1

Time
14

12 % and 200 cc increase in FEV1 and/or FVC
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Case spirometry
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Spirometry
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Spirometry
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Spirometry
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Level of severity
 ‘The intrinsic intensity of the disease process. Assess
asthma severity to initiate therapy.’
 Diagnoses
•
•
•
•

Intermittent
Mild persistent
Moderate persistent
Severe

 Impairment and Risk
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Severity Criteria
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Assessing control
 ‘The degree to which the manifestations of asthma are
minimized by therapeutic interventions and the goals of
therapy are met. Assess and monitor asthma control to
adjust therapy.’
Goal:
 Reduce impairment
• Well-controlled asthma is defined as use of rescue therapy 2 or fewer
times per week.
• SABA use prior to exercise is not rescue therapy.

 Reduce risk
• Prevent exacerbation
• Prevent loss of function
• Avoid side effects
21
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Control Criteria
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Asthma Treatment
 3 age groups
• 0-4 years of age
• 5-11 years of age
• > 12 years of age (youth and adult)

 6 steps
 Patient education and partnership (literacy-level sensitive)
• Self-management education
> Self-monitor
> AAP
> Inhaler/device technique

• Schedule follow up to assess responsiveness
> 2-6 weeks while gaining control
> 1-6 months is controlled
> 3 month interval if step-down is anticipated

 Environmental control
 Manage co-morbidities
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Asthma Treatment
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Asthma Action Plans (AAPs)
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AAPs
 Recommended for patients with persistent asthma
(especially requiring treatment at steps 4,5 or 6)
 Improved control through:
• Patient education
• Clear dosing
• More regular follow up to assess adherence
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Quality Study
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Asthma SmartForm
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Variables in HealthCare









FAHC ‘high reliability’
PRISM
TPCC
PCMH
VT Blueprint for Health
COM
Green Mountain Care
ACOs
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Quality Project
 Use the SmartForm – a robust PRISM platform
 Collaborate across Primary Care (Pediatrics, Family
Medicine and PCIM)
 Improve operations
 Improve outcomes in a chronic health condition
 Primary care outcomes research
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Operational plan
 Train all physicians, nurse practitioners and
physician assistants in asthma diagnosis, in
assessment of severity and control and in
management
 Train all nurses and providers in use of
spirometry, interpretation and indications
 Improve asthma outcomes
• Use asthma actions plans
• Use SmartForm for evidence based treatment plans
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Timeline









FM training – May 11th, 15th
Nurse in-service – June 6th
PCIM training – June 6th
Incorporate spirometry in workflow
Turn on SmartForm - by 7/2/12
FM resident training 8/2/12
Medicine resident training during August
Site based follow up
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Case – improving outcomes
 My patient was seen, given a spacer for her albuterol
inhaler and placed on Flovent 110 due to continued high
use of her rescue inhaler. At follow-up, she reported
decreased but continued albuterol use (only once a day)
and after any exercise.
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PRISM demonstration
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Asthma Summary
1.
2.
3.
4.
5.

It is a chronic disease
Spirometry can be diagnostic, quick and easy
Level of severity is consistent over time
Assessing control guides treatment
Asthma Action Plans can improve outcomes
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